New Delhi, 1st September 2021:
Making use of technological advancements to bring in higher efficiency, Çelebi Delhi Cargo Terminal Management, the joint venture between DIAL and Çelebi Ground Handling today announced that it has been accredited with IATA CEIV Pharma certification for its cargo and warehouse operations. Given the current scenario, the air cargo industry is calling for higher standards when transporting temperature sensitive pharmaceuticals. To cope with the growing expectation for standardization, the certification ensures international and national compliance to safeguard product integrity to its destination.
From the onset of the COVID-19 pandemic, Çelebi has done import and export of various types of vaccines, pharma, medical aid, and oxygen containers. Vaccine transfers require a controlled temperature and without delay to ensure the quality of the product in line with international regulatory requirements. Now, with this CEIV certification Celebi will be capable of building additional certified temperature control rooms as required.
Kamesh Peri, CEO, Çelebi Delhi Cargo Terminal Management said, “This is a prestigious certification to have, especially in present times with the highest standards expected in handling temperature-sensitive pharmaceuticals. We have achieved it after a thorough audit process performed by IATA who assessed and found our quality systems, infrastructure, procedures, and policies to be in absolute compliance. This was made possible by our committed team and I am very proud of their tireless & brilliant efforts.”
Çelebi has a state-of-the art Pharmaceutical Logistics Centre spread over 1200 sqm area. The Centre has a pre-cool facility and four chambers within the range of +15⁰c and -20⁰c, with a capacity of 72,000 MT annually. Recently, Çelebi also achieved GDP (Good Distribution Practice) certification for its Exports Pharma Logistics Centre and Pharma Processing Facility in Import for Çelebi Delhi Cargo Terminal.
